glp 1 药物 一月GLP-1进展不断：首款口服药获批，国产药将递交上市申请 A GLP-1 tsunami is headed
Description
R.MolloyM
There are currently three Food and Drug Administration (FDA)-approved DPP-4 inhibitors: sitagliptin, saxagliptin and linagliptin
Its very successful, Falardeau said
Gastrointestinal effects The most common consequence of early dosing is an increase in GI side effects
Effect of truncated glucagon-like peptide-1 [Proglucagon-(78107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach
